Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
0.9569
-0.1031 (-9.73%)
Mar 31, 2025, 2:31 PM EDT - Market open

Alzamend Neuro Statistics

Total Valuation

Alzamend Neuro has a market cap or net worth of $6.31 million. The enterprise value is $3.64 million.

Market Cap 6.31M
Enterprise Value 3.64M

Important Dates

The last earnings date was Monday, March 10, 2025, after market close.

Earnings Date Mar 10, 2025
Ex-Dividend Date n/a

Share Statistics

Alzamend Neuro has 6.60 million shares outstanding. The number of shares has increased by 294.83% in one year.

Current Share Class 6.60M
Shares Outstanding 6.60M
Shares Change (YoY) +294.83%
Shares Change (QoQ) +56.24%
Owned by Insiders (%) 0.83%
Owned by Institutions (%) 3.18%
Float 6.44M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.78
P/TBV Ratio 2.03
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.44

Current Ratio 5.44
Quick Ratio 4.63
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -221.65

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -106.08%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -121.98%
Revenue Per Employee n/a
Profits Per Employee -$603,848
Employee Count 7
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -89.61% in the last 52 weeks. The beta is -0.30, so Alzamend Neuro's price volatility has been lower than the market average.

Beta (5Y) -0.30
52-Week Price Change -89.61%
50-Day Moving Average 0.99
200-Day Moving Average 1.97
Relative Strength Index (RSI) 62.60
Average Volume (20 Days) 208,111

Short Selling Information

The latest short interest is 120,915, so 1.83% of the outstanding shares have been sold short.

Short Interest 120,915
Short Previous Month 228,201
Short % of Shares Out 1.83%
Short % of Float 1.88%
Short Ratio (days to cover) 0.14

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -4.21M
Pretax Income -9.95M
Net Income -4.23M
EBITDA -4.16M
EBIT -4.21M
Earnings Per Share (EPS) -$1.61
Full Income Statement

Balance Sheet

The company has $3.36 million in cash and n/a in debt, giving a net cash position of $3.36 million or $0.51 per share.

Cash & Cash Equivalents 3.36M
Total Debt n/a
Net Cash 3.36M
Net Cash Per Share $0.51
Equity (Book Value) 3.45M
Book Value Per Share 0.60
Working Capital 3.22M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$7.31 million and capital expenditures -$90,000, giving a free cash flow of -$7.40 million.

Operating Cash Flow -7.31M
Capital Expenditures -90,000
Free Cash Flow -7.40M
FCF Per Share -$1.12
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Alzamend Neuro does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -294.83%
Shareholder Yield n/a
Earnings Yield -60.44%
FCF Yield -105.76%

Analyst Forecast

The average price target for Alzamend Neuro is $20.00, which is 1,990.08% higher than the current price. The consensus rating is "Strong Buy".

Price Target $20.00
Price Target Difference 1,990.08%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) 27.15%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 16, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date Jul 16, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

Altman Z-Score n/a
Piotroski F-Score 1